<p>The Cox proportional hazard model adjusted for, age, sex, year of MI, concomitant medical treatment, socioeconomic status, and comorbidity. Reference group: no use of COX-2 inhibitors or NSAIDs. Error bars indicate 95% CIs.</p
Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial inf...
*<p>Cox models are adjusted for cohort, age, sex,</p>†<p>Cox models are further adjusted for smoking...
<p>Model 1: Cox proportional hazards model adjusted for age, sex, race, study center, education, smo...
<p>The Cox proportional hazard model adjusted for, age, sex, year of MI, concomitant medical treatme...
*<p>All models were adjusted for age, gender, eGFR, hemoglobin, previous infarction, hypertension, d...
<p>Variables in the model are as follows: age, gender, diabetes, hypertension, and the use of statin...
<p>a: adjusted by age and the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients who did not recei...
BackgroundUse of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been as...
BACKGROUND:Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been a...
AIMS: To quantify the association between treatment with nonsteroidal anti-inflammatory drugs (NSAID...
<p>Univariate model: Univariable analysis of adverse events using a Cox proportional hazards model.<...
BACKGROUND: Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been ...
The aim of this study was to evaluate the possibility of incorrect assessment of mortality risk fact...
<p>Results from adjusted multivariate Cox proportional hazard analyses. IR: Incidence rate per 100 p...
Objective To characterise the determinants, time course, and risks of acute myocardial infarction as...
Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial inf...
*<p>Cox models are adjusted for cohort, age, sex,</p>†<p>Cox models are further adjusted for smoking...
<p>Model 1: Cox proportional hazards model adjusted for age, sex, race, study center, education, smo...
<p>The Cox proportional hazard model adjusted for, age, sex, year of MI, concomitant medical treatme...
*<p>All models were adjusted for age, gender, eGFR, hemoglobin, previous infarction, hypertension, d...
<p>Variables in the model are as follows: age, gender, diabetes, hypertension, and the use of statin...
<p>a: adjusted by age and the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in patients who did not recei...
BackgroundUse of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been as...
BACKGROUND:Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been a...
AIMS: To quantify the association between treatment with nonsteroidal anti-inflammatory drugs (NSAID...
<p>Univariate model: Univariable analysis of adverse events using a Cox proportional hazards model.<...
BACKGROUND: Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been ...
The aim of this study was to evaluate the possibility of incorrect assessment of mortality risk fact...
<p>Results from adjusted multivariate Cox proportional hazard analyses. IR: Incidence rate per 100 p...
Objective To characterise the determinants, time course, and risks of acute myocardial infarction as...
Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial inf...
*<p>Cox models are adjusted for cohort, age, sex,</p>†<p>Cox models are further adjusted for smoking...
<p>Model 1: Cox proportional hazards model adjusted for age, sex, race, study center, education, smo...